Search
for
Sort by
Research 121–150 of 611
- Therapeutic Potential of Vitex negundo for the Treatment of Polycystic Ovarian Disease (PCOD): A Review
- JAK-centric explainable few-shot gene-expression diagnosis framework for alopecia via MultiPLIER priors and relation-style set-to-set comparison
- Elevated serum chromogranin A levels are independently associated with metabolic and inflammatory disturbances in polycystic ovary syndrome
- Androgen receptor gene polymorphism and biological age markers in men
- Factors associated with early-onset androgenetic alopecia: A scoping review
- ‘’Brown adipose tissue in the form of innovative approach for polycystic ovary syndrome treatment-still long time to reach clinical arena: a narrative review’’
- Role of Metformin in Acanthosis Nigricans
- Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart
- Unusual patterns of presentation of frontal fibrosing alopecia: A clinical and trichoscopic analysis of 98 patients
- Polycystic ovary syndrome: insight into pathogenesis and a common association with insulin resistance
- Polycystic ovary syndrome: A review for dermatologists
- The Optimal Indication for Testosterone Replacement Therapy in Late Onset Hypogonadism
- Functional Ingredient Mapping in PCOS Formulations: Hormonal Excess
- Polycystic ovary syndrome: the impact of diet and physical activity on the course of the disease
- Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria
- Sex differences in the hypothalamic–pituitary–adrenal axis’ response to stress: an important role for gonadal hormones
- Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression
- COVID-19 and Sex Differences
- Testosterone therapy for transgender men
- Extraskeletal actions of vitamin D
- Nonalcoholic fatty liver disease and polycystic ovary syndrome
- Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database
- Polycystic Ovary Syndrome: Update on Diagnosis and Treatment
- Obesity and polycystic ovary syndrome
- What causes hidradenitis suppurativa ?—15 years after
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- Recent advances in the molecular mechanisms determining tissue sensitivity to glucocorticoids: novel mutations, circadian rhythm and ligand-induced repression of the human glucocorticoid receptor
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome
- Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients